By Matt Skoufalos
Change Healthcare, the Nashville, Tennessee-based joint venture of McKesson Corp. and Change Healthcare Holdings Inc., has announced its executive team. CEO Neil de Crescenzo heads the organization, which also includes EVP and CFO Randy Giles, EVP and President of Software and Analytics Rod O’Reilly, EVP and President of Imaging, Workflow, and Care Solutions Erkan Akyuz; EVP & President of Network Solutions Kris Joshi; EVP and President of Technology-Enabled Services, Pat Leonard; EVP of Sales and Operations Mark Vachon; EVP and General Counsel Loretta Cecil; EVP of Research and Development and CIO Alex Choy; EVP and Chief People Officer Linda Whitley-Taylor; EVP and Chief Marketing Officer W. Thomas McEnery; and SVP and Chief Strategy Officer Megan Callahan.
InterMed of Alachua, Florida has added Brian Poplin, President-CEO of Elior North America to its board of directors. Poplin has also been President and CEO of both the former TrustHouse Services Group and of Medical Staffing Network. He is a USAF veteran and certified biomed who also holds a master’s of science in business management and a doctorate in health administration and policy from the Medical University of South Carolina.
Bridge Medicines of New York, New York has named William J. Polvino its CEO, replacing interim CEO Kathleen Metters, who held the post since the company’s establishment in October 2016. Metters will stay with Bridge Medicines in an operating role while chairing its scientific advisory board. Polvino, a pharmaceutical entrepreneur, will leverage his 26 years of experience in helping the company develop its portfolio of drug discovery projects. He joins Bridge Medicines from Veloxis Pharmaceuticals, where he was President and CEO; Polvino was also president and CEO of Helsinn Therapeutics, and has held executive and senior-level positions in drug development at Merck, Wyeth, and Theravance.
William J. Polvino
Integrated Healing Technologies of Franklin, Tennessee has named Tod Brindle its VP of Clinical Affairs. Brindle joins the company from Virginia Commonwealth University Medical Center, where he was the wound care team nurse clinician and clinical administrator. Brindle has a master’s of science in nursing, administration, and leadership from Virginia Commonwealth University (VCU) and is also completing a PhD in nursing from VCU.
Sysmex America, Inc. (SAI) of Lincolnshire, Illinois has named EVP Ralph Taylor its CEO, replacing current SAI board chairman, CEO, and president John Kershaw. Kershaw, a founding member of Sysmex UK Limited, has held the post since 2009; he will move to SAI headquarters in Kobe, Japan to become deputy in charge of business strategy development, hematology/urinalysis, immunochemistry/clinical chemistry/hemostasis and engineering. Andy Hay, another founding member of Sysmex UK Ltd., will be promoted from EVP to COO, while CFO Alex Garini will see his role expanded to include oversight of regional manufacturing facilities.
After an executive search, Dynatronics of Cottonwood Heights, Utah has named Cynthia L. McHenry its VP of Operations. McHenry joins the company from St. Jude Medical (Abbott), where she spent 20 years, most recently as Senior Director of Global Operations Integration and Site Optimization. McHenry will serve on Dynatronics executive management team, participating in acquisitions planning and integration of acquisitions. She succeeds Doug Sampson, who has been appointed VP of Research, Development and Quality Systems.
Providence Medical Technology of Walnut Creek, California, has named Scott Lynch head of Global Marketing and Michael Scott head of International leadership. Lynch has 22 years of medical device and 15 years of spine industry marketing experience having previously served as Vice President of Global Marketing at DFINE, VertiFlex, and Zimmer Spine. Scott has 16 years of experience including as VP of OUS Sports Medicine and of Asia Pacific Commercial Operations at ArthroCare, and at Smith & Nephew, where he was US Vice President of ENT Sales.
The California Chiropractic Association of Sacramento, California has made Dawn Benton its executive director. Benton has 11 years of nonprofit experience including as the founder of organizational operations consultancy Brover Consulting, president and CEO of the Associated Builders and Contractors of Southern California, and work with the California Society of Health-System Pharmacists.
Maxor National Pharmacy Services of Amarillo, Texas has named Leah Bailey its General Counsel. Bailey has 13 years of experience in corporate law, and joins Maxor from Prime Therapeutics, where she advised its PBM, specialty, and mail order business areas on regulatory and contractual matters. She has a Juris Doctor degree from the University of Minnesota Law School and has worked as a case manager for homeless victims of domestic violence and their children.
Astellas of Northbrook, Illinois has promoted Pharmaceutical Technology Management Executive Director John DeMay to president of Astellas US Technologies, Inc. (AUST). DeMay will help the company’s pharmaceutical technology divisions across the Americas collaborate, will manage the AUST Northbrook site, and will also continue to head its project and product management group. DeMay joined Astellas in 2002, and has served as associate director of technical services and senior director of its CMC technology group. He has bachelor’s degrees in biology and in pharmacy.
Paul M. Bisaro
Impax Laboratories of Hayward, California has named Paul M. Bisaro its President and CEO, and has added Bisaro to its board of directors. Bisaro succeeds interim President-CEO J. Kevin Buchi, and brings with him 25 years of generic and branded pharmaceutical experience. Bisaro has been executive chairman of Allergan, president-CEO and chairman of the board of Actavis (formerly Watson Pharmaceuticals, Inc.), and president-COO and director of Barr Pharmaceuticals, Inc. Bisaro will retain his seats on the boards of directors of Allergan, of Zoetis, Inc. and on the Board of Visitors of the Catholic University of America’s Columbus School of Law, but will not stand for re-election as a director at Zimmer Biomet Holdings, Inc.